Pegapamodutide, a cutting-edge biomedical marvel, emerges as a beacon of hope in the quest to mitigate the multifaceted manifestations of type 2 diabetes. Through intricate interactions with the esteemed GLP-1 receptors, this transcendent pharmaceutical masterpiece exerts its influence, stimulating insulin secretion contingent upon glucose levels and meticulously overseeing the delicate balance of blood glucose.
CAT No: R2066
CAS No: 1492924-65-8
Synonyms/Alias: Pegapamodutide;Pegapamodutide [USAN];UNII-WG4ID2U7FT;WG4ID2U7FT;LY2944876;Pegapamodutide (USAN);pegapamodutida;pegapamodutidum;CAS Registry Number;PEGAPAMODUTIDE [INN];PEGAPAMODUTIDE [WHO-DD];LY-2944876;Q27292621;1492924-65-8;
Chemical Name: (2R)-2-amino-3-[1-[3-[3-(2-methoxyethoxy)propylamino]-3-oxopropyl]-2,5-dioxopyrrolidin-3-yl]sulfanylpropanoic acid
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C16H27N3O7S |
M.W/Mr. | 405.5 |
InChI | InChI=1S/C16H27N3O7S/c1-25-7-8-26-6-2-4-18-13(20)3-5-19-14(21)9-12(15(19)22)27-10-11(17)16(23)24/h11-12H,2-10,17H2,1H3,(H,18,20)(H,23,24)/t11-,12?/m0/s1 |
InChI Key | DLVAZTPQKCTPLB-PXYINDEMSA-N |
Canonical SMILES | COCCOCCCNC(=O)CCN1C(=O)CC(C1=O)SCC(C(=O)O)N |
Isomeric SMILES | COCCOCCCNC(=O)CCN1C(=O)CC(C1=O)SC[C@@H](C(=O)O)N |
1. High fat diet and GLP-1 drugs induce pancreatic injury in mice
2. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com